Top Markets
Coin of the day
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
Rangering i aksjer #30975
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
Aksjekurs
$0.13577832
Markedsverdi
$14.83M
Endring (1 dag)
-2.63%
Endring (1 år)
44.13%
Land
CA
Handel Pharmala Biotech Holdings Inc. (MDMA)

Kategori

P/B-forhold for Pharmala Biotech Holdings Inc. (MDMA)
P/B-forhold per 2026 TTM: 0
Ifølge Pharmala Biotech Holdings Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Pharmala Biotech Holdings Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.4612 -
BE